U.S. Food and Drug Administration - CDRH Mobile
Skip NavigationFDA Logo links to FDA home pageCenter for Devices and Radiological Health, U.S. Food and Drug AdministrationHHS Logo links to Department of Health and Human Services website
FDA Home Page | CDRH Home Page | Search | A-Z Index U.S. Food and Drug AdministrationCenter for Devices and Radiological Health Questions?
horizonal rule

PDF Printer VersionImportant Information on the Medical Device User Fee Rates for FY2009

Dear Registered Establishment:

The United States Food and Drug Administration (US FDA) is publishing the fee rates and payment procedures for medical device user fees for fiscal year 2009 (October 1, 2008-September 30, 2009). The Federal Food, Drug, and Cosmetic Act (FD&C), as amended by the Medical Device User Fee Amendments of 2007 (”the 2007 Amendments”) authorizes FDA to collect user fees for certain medical device applications. These fees apply to Premarket Approvals (PMAs), Product Development Protocols (PDPs), Premarket Reports (PMRs), Biologics Licensing Applications (BLAs for certain medical devices reviewed by FDA's Center for Biologics Evaluation and Research), some supplements, and Premarket Notifications [510(k)s]. In addition, the 2007 Amendments authorize FDA to collect fees for 30-day notices, requests for classification information (513g), and annual fees for periodic reporting on class III medical devices and for the registration of certain medical device establishments.

Payment for your submission must be received on or before the time you send your submission to FDA; the annual establishment registration fee must be paid between October 1, 2008 and December 31, 2008. If an applicant has not paid all fees owed, FDA will consider the application incomplete and will not accept it for filing or review. Small businesses may qualify for a waiver or a reduced fee on certain submissions to FDA.

Fees for Establishment Registration

There are no reduced fees for small business establishment registration; every establishment pays the same fee.

An owner or operator must register within 30 days after entering into an operation defined in 21 CFR 807.20. The 2007 Amendments changed section 510(p) of the act to require electronic submission of registration and listing information. This includes both the initial registration and annual registration. You will list your medical devices at the same time, but there is no fee for device listing. Please see enclosed letter that addresses who is subject to a fee for registration. For fiscal year 2009 (October 1, 2008 through September 30, 2009), the registration fee for each establishment that performs the types of activities which require payment is:

FY 2009 Establishment Registration Fee is $1,851 U.S. Dollars

Again, there are no reduced fees for small business establishment registration; every establishment pays the same fee.

Small Businesses; Fee Waiver and Fee Reduction regarding certain Medical Device Applications

In an effort to reduce the burden on small businesses, FDA provides a reduced rate for firms that meet the definition of a small business. The definition of a small business has not changed since 2006, i.e. $100 million or less in gross receipts or sales, including that of all affiliates. Small firms with gross receipts or sales of $30 million or less are eligible to have the fee on their first PMA waived. Firms based in the U.S. and firms based outside the U.S. may apply to FDA to qualify for a small business fee reduction.

Fees for Review of Premarket Notification [510(k)s] and Response to Request for Classification Information [513g]

For fiscal year 2009 (October 1, 2008 through September 30, 2009), the fee for 510(k) review and 513(g) response are the following.

FY 2009 Device Review User Fees (U.S. Dollars)

Application

Standard Fee

Small Business (≤$100 million in
gross receipts or sales) Fee

510(k)

$3,693

$1,847

513(g) $2,710 $1,355

All types of 510(k)s — Traditional, Abbreviated, and Special — are subject to the fee, but there is no fee for a 510(k) initially reviewed by an FDA-accredited third-party.

The FY2009 fees apply to applications received on or after October 1, 2008. If both the application and payment are received prior to October 1, 2008, you should pay the FY 2008 fee.

Do NOT send payment to FDA with your application. Additional information, including instructions on how and where to send payment and how to qualify as a small business, is available at http://www.fda.gov/cdrh/devadvice/314a.html.

Fees for Review of Premarket Applications

For fiscal year 2009 (October 1, 2008 through September 30, 2009), the fees for these applications are:

FY 2009 Device Review User Fees (U.S. Dollars)

Application

Standard Fee

Small Business

Premarket Application (PMA, PDP, BLA, PMR)

$200,725

$50,181

First premarket application from firms with
gross receipts or sales ≤ $30 million

Not Applicable

Fee is Waived

Panel-track Supplement

$150,544

$37,636

Efficacy Supplement (for BLA)

$200,725

$50,181

180-day Supplement

$30,109

$7,527

Real-time Supplement $14,051 $3,513
30-day Notice $3,212 $1,606

FY 2009 Annual Fee for Periodic Reporting on a Class III Device (U.S. Dollars)

Standard Fee

Small Business

Annual fee for periodic reporting on a class III device

$7,025

$1,756

 The FY2009 fees apply to applications received on or after October 1, 2008. If the application and payment are received prior to October 1, 2008, applicants should pay the FY 2008 fee.

Do NOT send payment to FDA with your application. Additional information, including instructions on how and where to send payment and how to qualify as a small business, is available at http://www.fda.gov/cdrh/devadvice/pma/userfees.html

Fees for FY 2010 and subsequent years will be published in the Federal Register 60 days before the start of each fiscal year.

The Division of Small Manufacturers, International and Consumer Assistance (DSMICA) can answer questions concerning the new law and help you find guidance documents and other reference materials. DSMICA can be contacted by phone at 800-638-2041 or 240-276-3150 or by email at DSMICA@FDA.HHS.GOV. Questions regarding products regulated by the Center for Biologics Evaluation and Research should be directed to the Office of Communication, Training and Manufacturers Assistance (OCTMA). OCTMA can be contacted by phone at (301) 827-2000 or (800) 835-4709 or by email at MATT@CBER.FDA.GOV

Further information regarding medical device user fees is available at: http://www.fda.gov/cdrh/mdufma.

Sincerely yours,

John F. Stigi
Director, DSMICA
Center for Devices and Radiological Health
U.S. Food and Drug Administration

Updated August 13, 2008

horizonal rule

CDRH Home Page | CDRH A-Z Index | Contact CDRH | Accessibility | Disclaimer
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | HHS Home Page

Center for Devices and Radiological Health / CDRH